Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Rossella Rodia, Stefano Marini, Fabiana Pani, Francesco Boi & Stefano Mariotti. (2019) Embolization of Iliac Metastasis During Lenvatinib Treatment in Patient with Advanced HüRthle Cell Thyroid Carcinoma. Future Oncology 15:sup24, pages 35-40.
Read now
Read now
Ian Gilron. (2016) Impact of Chronobiology on Neuropathic Pain Treatment. Pain Management 6:3, pages 241-247.
Read now
Read now
Chiara Ciccarese, Alessandra Modena, Giampaolo Tortora & Francesco Massari. (2015) Kidney Cancer and 2014: Is Innovation Really Over?. Future Oncology 11:9, pages 1437-1449.
Read now
Read now
Stijn Muselaers, Peter Mulders, Egbert Oosterwijk, Wim Oyen & Otto Boerman. (2013) Molecular Imaging and Carbonic Anhydrase IX-Targeted Radioimmunotherapy in Clear Cell Renal Cell Carcinoma. Immunotherapy 5:5, pages 489-495.
Read now
Read now
Francisco J Quintana. (2013) Nanoparticles for the Induction of Antigen-Specific Tregs. Immunotherapy 5:5, pages 437-440.
Read now
Read now
Ziyad Binkhathlan & Aws Alshamsan. (2012) Emerging Nanodelivery Strategies of RNAi Molecules for Colon Cancer Therapy: Preclinical Developments. Therapeutic Delivery 3:9, pages 1117-1130.
Read now
Read now
Wanfeng Guo, Xiaoqing Liu & Hongjun Gao. (2011) Flare up of symptoms after discontinuation of sunitinib in patient with lung cancer. Acta Oncologica 50:7, pages 1133-1135.
Read now
Read now
Elena Rusconi & Andreas Kleinschmidt. (2010) Gerstmann‘s syndrome: where does it come from and what does that tell us?. Future Neurology 6:1, pages 23-32.
Read now
Read now
Lucy M Elphick, Sarah E Lee, Alexandra A Anderson, Emma S Child, Laurent Bonnac, Véronique Gouverneur & David J Mann. (2009) Exploring the Roles of Protein Kinases Using Chemical Genetics. Future Medicinal Chemistry 1:7, pages 1233-1241.
Read now
Read now
Cheryl A Frye. (2009) Progestogens Influence Cognitive Processes in Aging. Future Medicinal Chemistry 1:7, pages 1215-1231.
Read now
Read now
Articles from other publishers (42)
Mohamed J. Saadh, Morug Salih Mahdi, Omer Qutaiba B. Allela, Tuqa S. Alazzawi, Mohammed ubaid, Nodir M. Rakhimov, Zainab H. Athab, Pushpamala Ramaiah, Lathamangeswari Chinnasamy, Fahad Alsaikhan & Bagher Farhood. (2024) Critical role of miR-21/exosomal miR-21 in autophagy pathway. Pathology - Research and Practice 257, pages 155275.
Crossref
Crossref
Paulina Marona, Judyta Górka, Oliwia Kwapisz, Jolanta Jura, Janusz Rys, Robert M. Hoffman & Katarzyna Miekus. (2022) Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation. Cell Death & Disease 13:9.
Crossref
Crossref
Adam Hargreaves, Simon T. Barry, Alison Bigley, Jane Kendrew & Shirley Price. (2022) Tumours modulate the systemic vascular response to anti‐angiogenic therapy. Journal of Applied Toxicology 42:8, pages 1371-1384.
Crossref
Crossref
Maohua Huang, Minfeng Chen, Ming Qi, Geni Ye, Jinghua Pan, Changzheng Shi, Yunlong Yang, Luyu Zhao, Xukai Mo, Yiran Zhang, Yong Li, Jincheng Zhong, Weijin Lu, Xiaobo Li, Jiayan Zhang, Jinrong Lin, Liangping Luo, Tongzheng Liu, Patrick Ming‐Kuen Tang, An Hong, Yihai Cao, Wencai Ye & Dongmei Zhang. (2021) Perivascular cell‐derived extracellular vesicles stimulate colorectal cancer revascularization after withdrawal of antiangiogenic drugs. Journal of Extracellular Vesicles 10:7.
Crossref
Crossref
Donald J. AbrahamLei Shi. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
66
.
Mali Amirault, Sylvia Choo, Timothy Waxweiler, Sarah D. Weisdack, Kathryn Breaker, Thomas W. Flaig & Elaine T. Lam. (2021) Tumor flare of brain metastases upon dose interruption of sunitinib in a patient with metastatic renal cell carcinoma. Cancer Treatment and Research Communications 27, pages 100367.
Crossref
Crossref
Laiyan Zhou, Mai Zhang, Rui Li, Jianxin Xue & You Lu. (2020) Pseudoprogression and hyperprogression in lung cancer: a comprehensive review of literature. Journal of Cancer Research and Clinical Oncology 146:12, pages 3269-3279.
Crossref
Crossref
Tung On Yau. (2019) Precision treatment in colorectal cancer: Now and the future. JGH Open 3:5, pages 361-369.
Crossref
Crossref
Taisuke Uchida, Hideki Yamaguchi, Kazuhiro Nagamine, Tadato Yonekawa, Eriko Nakamura, Nobuhiro Shibata, Fumiaki Kawano, Yujiro Asada & Masamitsu Nakazato. (2019) Rapid pleural effusion after discontinuation of lenvatinib in a patient with pleural metastasis from thyroid cancer. Endocrinology, Diabetes & Metabolism Case Reports 2019.
Crossref
Crossref
Kayo Inoue, Hiroshi Tsubamoto, Roze Isono-Nakata, Kazuko Sakata & Nami Nakagomi. (2018) Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report. BMC Cancer 18:1.
Crossref
Crossref
Stéphane Champiat, Roberto Ferrara, Christophe Massard, Benjamin Besse, Aurélien Marabelle, Jean-Charles Soria & Charles Ferté. (2018) Hyperprogressive disease: recognizing a novel pattern to improve patient management. Nature Reviews Clinical Oncology 15:12, pages 748-762.
Crossref
Crossref
Nili Dahan, Ksenia Magidey & Yuval Shaked. 2018. Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways. Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
211
236
.
Fabiana Pani, Elisabetta Macerola, Fulvio Basolo, Francesco Boi, Mario Scartozzi & Stefano Mariotti. (2017) Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report. Oncology Letters 14:2, pages 2186-2190.
Crossref
Crossref
Brian M. Shinder, Kevin Rhee, Douglas Farrell, Nicholas J. Farber, Mark N. Stein, Thomas L. Jang & Eric A. Singer. (2017) Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach. Frontiers in Oncology 7.
Crossref
Crossref
Terumi Tanigawa, Shintaro Morisaki, Hisanobu Fukuda, Shuichiro Yoshimura, Hisayoshi Nakajima & Kohei Kotera. (2017) Tumors Sharply Increased after Ceasing Pazopanib Therapy for a Patient with Advanced Uterine Leiomyosarcoma: Experience of Tumor Flare. Case Reports in Obstetrics and Gynecology 2017, pages 1-4.
Crossref
Crossref
Xiangxuan Zhao, Mengde Cao, Zaiming Lu, Ton Wang, Ying Ren, Chen Liu & David Nelson. (2016) Small-molecule inhibitor sorafenib regulates immunoreactions by inducing survival and differentiation of bone marrow cells. Innate Immunity 22:7, pages 493-502.
Crossref
Crossref
E Schindler, MA Amantea, MO Karlsson & LE Friberg. (2016) PK‐PD modeling of individual lesion FDG‐PET response to predict overall survival in patients with sunitinib‐treated gastrointestinal stromal tumor. CPT: Pharmacometrics & Systems Pharmacology 5:4, pages 173-181.
Crossref
Crossref
Roberto Iacovelli, Francesco Massari, Laurence Albiges, Yohann Loriot, Christophe Massard, Karim Fizazi & Bernard Escudier. (2015) Evidence and Clinical Relevance of Tumor Flare in Patients Who Discontinue Tyrosine Kinase Inhibitors for Treatment of Metastatic Renal Cell Carcinoma. European Urology 68:1, pages 154-160.
Crossref
Crossref
Keun-Yeong Jeong, Eun-Jung Lee, Seung-Hyun Yang & Jinsil Seong. (2015) Combination of macrophage inflammatory protein 1 alpha with existing therapies to enhance the antitumor effects on murine hepatoma. Journal of Radiation Research 56:1, pages 37-45.
Crossref
Crossref
Naveen S. Vasudev & Andrew R. Reynolds. (2014) Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis 17:3, pages 471-494.
Crossref
Crossref
Wen-Quan Wang, Liang Liu, Hua-Xiang Xu, Hui-Chuan Sun, Chun-Tao Wu, Xiao-Dong Zhu, Wei Zhang, Jin Xu, Chen Liu, Jiang Long, Quan-Xing Ni, Zhao-You Tang & Xian-Jun Yu. (2014) The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib. Oncotarget 5:11, pages 3895-3906.
Crossref
Crossref
Constantijn H.J. Muselaers, Egbert Oosterwijk, Desirée L. Bos, Wim J.G. Oyen, Peter F.A. Mulders & Otto C. Boerman. (2014) Optimizing Lutetium 177–Anti–Carbonic Anhydrase IX Radioimmunotherapy in an Intraperitoneal Clear Cell Renal Cell Carcinoma Xenograft Model. Molecular Imaging 13:4, pages 7290.2014.00008.
Crossref
Crossref
Qingfeng Xiang, Weiqiang Chen, Meng Ren, Jingnan Wang, Hongwu Zhang, David Y.B. Deng, Lei Zhang, Changzhen Shang & Yajin Chen. (2014) Cabozantinib Suppresses Tumor Growth and Metastasis in Hepatocellular Carcinoma by a Dual Blockade of VEGFR2 and MET. Clinical Cancer Research 20:11, pages 2959-2970.
Crossref
Crossref
Koji Miyahara, Kazuhiro Nouso, Yuki Morimoto, Yasuto Takeuchi, Hiroaki Hagihara, Kenji Kuwaki, Hideki Onishi, Fusao Ikeda, Yasuhiro Miyake, Shinichiro Nakamura, Hidenori Shiraha, Akinobu Takaki, Shouta Iwadou, Yoshiyuki Kobayashi, Koichi Takaguchi, Yoshitaka Takuma, Hiroyuki Takabatake, Kohsaku Sakaguchi & Kazuhide Yamamoto. (2013) Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma. Hepatology Research 44:3, pages 296-301.
Crossref
Crossref
Constantijn H.J. Muselaers, Alexander B. Stillebroer, Ingrid M.E. Desar, Marye J. Boers-Sonderen, Carla M.L. van Herpen, Mirjam C.A. de Weijert, Johan F. Langenhuijsen, Egbert Oosterwijk, William P.J. Leenders, Otto C. Boerman, Peter F.A. Mulders & Wim J.G. Oyen. (2014)
Tyrosine Kinase Inhibitor Sorafenib Decreases
111
In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma
. Journal of Nuclear Medicine 55:2, pages 242-247.
Crossref
Crossref
Kyung-Jin YunWoohyeon KimEun Hee KimMin-Hee KimDong-Jun LimMoo-Il KangBong-Yun Cha. (2014) Accelerated Disease Progression after Discontinuation of Sorafenib in a Patient with Metastatic Papillary Thyroid Cancer. Endocrinology and Metabolism 29:3, pages 388.
Crossref
Crossref
Hidenori Fujita, Kazutaka Miyadera, Masanori Kato, Yayoi Fujioka, Hiroaki Ochiiwa, Jinhong Huang, Kimihiro Ito, Yoshimi Aoyagi, Toru Takenaka, Takamasa Suzuki, Satoko Ito, Akihiro Hashimoto, Takashi Suefuji, Kosuke Egami, Hideki Kazuno, Yoshimitsu Suda, Kazuto Nishio & Kazuhiko Yonekura. (2013)
The Novel VEGF Receptor/MET–Targeted Kinase Inhibitor TAS-115 Has Marked
In Vivo
Antitumor Properties and a Favorable Tolerability Profile
. Molecular Cancer Therapeutics 12:12, pages 2685-2696.
Crossref
Crossref
S. Bellou, G. Pentheroudakis, C. Murphy & T. Fotsis. (2013) Anti-angiogenesis in cancer therapy: Hercules and hydra. Cancer Letters 338:2, pages 219-228.
Crossref
Crossref
T. Powles, I. Kayani, K. Sharpe, L. Lim, J. Peters, G.D. Stewart, D. Berney, A. Sahdev, S. Chowdhury, E. Boleti, J. Shamash, A.R. Reynolds, R. Jones, C. Blank, J. Haanen & A. Bex. (2013) A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer. Annals of Oncology 24:8, pages 2098-2103.
Crossref
Crossref
Grace K. Dy & Alex A. Adjei. (2013) Understanding, recognizing, and managing toxicities of targeted anticancer therapies. CA: A Cancer Journal for Clinicians 63:4, pages 249-279.
Crossref
Crossref
Lu Lu, Hui-Chuan Sun, Wei Zhang, Zong-Tao Chai, Xiao-Dong Zhu, Ling-Qun Kong, Wen-Quan Wang, Ke-Zhi Zhang, Yuan-Yuan Zhang, Qiang-Bo Zhang, Jian-Yang Ao, Jia-Qi Li, Lu Wang, Wei-Zhong Wu & Zhao-You Tang. (2013) Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating HTATIP2 in Hepatocellular Carcinoma. PLoS ONE 8:5, pages e65023.
Crossref
Crossref
Wei Zhang, Hui–Chuan Sun, Wen–Quan Wang, Qiang–Bo Zhang, Peng–Yuan Zhuang, Yu–Quan Xiong, Xiao–Dong Zhu, Hua–Xiang Xu, Ling–Qun Kong, Wei–Zhong Wu, Lu Wang, Tian–Qiang Song, Qiang Li & Zhao–You Tang. (2012) Sorafenib Down-regulates Expression of HTATIP2 to Promote Invasiveness and Metastasis of Orthotopic Hepatocellular Carcinoma Tumors in Mice. Gastroenterology 143:6, pages 1641-1649.e5.
Crossref
Crossref
Shuning He, Gerda EM Lamers, Jan‐Willem M Beenakker, Chao Cui, Veerander PS Ghotra, Erik HJ Danen, Annemarie H Meijer, Herman P Spaink & B Ewa Snaar‐Jagalska. (2012) Neutrophil‐mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. The Journal of Pathology 227:4, pages 431-445.
Crossref
Crossref
Arjan W. Griffioen, Laurie A. Mans, Annemarie M.A. de Graaf, Patrycja Nowak-Sliwinska, Céline L.M.M. de Hoog, Trees A.M. de Jong, Florry A. Vyth-Dreese, Judy R. van Beijnum, Axel Bex & Eric Jonasch. (2012) Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients. Clinical Cancer Research 18:14, pages 3961-3971.
Crossref
Crossref
Benedetto Farsaci, Jack P. Higgins & James W. Hodge. (2011) Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy. International Journal of Cancer 130:8, pages 1948-1959.
Crossref
Crossref
Irfan Kayani, Norbert Avril, Jamshed Bomanji, Simon Chowdhury, Andrea Rockall, Anju Sahdev, Paul Nathan, Peter Wilson, Jonathan Shamash, Kevin Sharpe, Louise Lim, John Dickson, Peter Ell, Andrew Reynolds & Thomas Powles. (2011) Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer. Clinical Cancer Research 17:18, pages 6021-6028.
Crossref
Crossref
T. Powles, S. Chowdhury, J. Shamash, A. Bazeos, S. Gillessen, N. Saunders, L. Lim, N. Sarwar, A. Sadev, P. Wilson, P. Nathan, K. Boleti, J. Peters & S. Agrawal. (2011) Increased haematopoietic progenitor cells are associated with poor outcome in patients with metastatic renal cancer treated with sunitinib. Annals of Oncology 22:4, pages 815-820.
Crossref
Crossref
John M. L. Ebos & Robert S. Kerbel. (2011) Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nature Reviews Clinical Oncology 8:4, pages 210-221.
Crossref
Crossref
Terence C. Tang, Shan Man, Ping Xu, Giulio Francia, Kae Hashimoto, Urban Emmenegger & Robert S. Kerbel. (2010) Development of a Resistance-like Phenotype to Sorafenib by Human Hepatocellular Carcinoma Cells Is Reversible and Can Be Delayed by Metronomic UFT Chemotherapy. Neoplasia 12:11, pages 928-940.
Crossref
Crossref
Robert S Kerbel & John M L Ebos. (2010) Peering into the aftermath: The inhospitable host?. Nature Medicine 16:10, pages 1084-1085.
Crossref
Crossref
Astrid A. M. van der Veldt, Martijn R. Meijerink, Alfons J. M. van den Eertwegh & Epie Boven. (2010) Targeted therapies in renal cell cancer: recent developments in imaging. Targeted Oncology 5:2, pages 95-112.
Crossref
Crossref
Terence C. Tang, Shan Man, Christina R. Lee, Ping Xu & Robert S. Kerbel. (2010) Impact of Metronomic UFT/Cyclophosphamide Chemotherapy and Antiangiogenic Drug Assessed in a New Preclinical Model of Locally Advanced Orthotopic Hepatocellular Carcinoma. Neoplasia 12:3, pages 264-274.
Crossref
Crossref